Table 2. Associations between antibodies and clinical parameters among pregnant women.
| Clinical parameter | No. | Parasitemia | Birth weight | Hemoglobin | Maternal age |
|---|---|---|---|---|---|
| Correlations with adhesion inhibitiona | |||||
| All cases | 39 | 0.076 | −0.127 | −0.174 | 0.0821 |
| PG cases | 27 | 0.033 | −0.172 | −0.259 | −0.013 |
| All MG | 25 | NA | 0.288 | 0.083 | 0.166 |
| PG and MGb | 52 | NA | −0.132 | −0.074 | −0.026 |
| Correlations with IgG bindinga | |||||
| All cases | 43 | −0.151 | 0.130 | −0.201 | −0.106 |
| PG cases | 30 | −0.095 | 0.166 | −0.234 | −0.337c |
| All MG | 27 | NA | 0.107 | 0.090 | −0.204 |
| PG and MGb | 57 | NA | 0.152 | −0.091 | −0.133 |
| Agglutinating antibodiesd | |||||
| Positive | 36 | 9.8% | 2826 g | 10.9 g/dL | 20.9 years |
| Negative | 23 | 11.3% | 2576 | 11.2 g/dL | 21.2 years |
NOTE. CS2 Plasmodium falciparum-infected red blood cells (PRBCs) were used for all assays. MG, multigravida; NA, not applicable; PG, primigravida.
Data are correlation coefficients.
Does not include uninfected PG who had a very low prevalence of antibodies.
Borderline statistical significance (P =.069). All other correlations and associations were not statistically significant (P> .1).
Data are means.